Citation Impact
Citing Papers
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
2010 StandoutScience
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
2007
Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol
2011
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
2011
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Escitalopram in the treatment of major depressive disorder: A meta-analysis
2008
The Medical Management of Depression
2005
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Altered fecal microbiota composition in patients with major depressive disorder
2015 Standout
Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome
2009
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report
2006
Cognition and Depression: Current Status and Future Directions
2010 Standout
Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal Pain
2009
Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder
2011
Depression
2018 Standout
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial
2016
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder
2006
Major depressive disorder
2016 Standout
Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study
2007
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder
2008
Psychological therapies for the management of chronic pain (excluding headache) in adults
2012 Standout
Long‐term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression
1992
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Collaborative Care for Bipolar Disorder: Part I. Intervention and Implementation in a Randomized Effectiveness Trial
2006
Residual symptoms after partial remission: an important outcome in depression
1995
Effectiveness-implementation Hybrid Designs
2012 Standout
Paroxetine: current status in psychiatry
2007
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
A systematic review of evidence for the added benefits to health of exposure to natural environments
2010 Standout
Abuse, Trauma, and GI Illness: Is There a Link?
2010
Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression
2007
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
2010 Standout
The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients
2005 Standout
Collaborative Care for Bipolar Disorder: Part II. Impact on Clinical Outcome, Function, and Costs
2006
Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?
2005
Clinical issues in considering vagus nerve stimulation for treatment-resistant depression
2009
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model
2011
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
2009 Standout
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
2017
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Predictors of Drug Response in Depression
1989
A Comparison of Lithium and T 3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report
2006
The Antidepressive Effects of Exercise
2009
Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care
2007
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
2008
Pharmacogenetics of Antidepressants
2011
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study
2004
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
2008 Standout
Major Depressive Disorder
2008 Standout
Decline in Cardiorespiratory Fitness and Odds of Incident Depression
2012
Depression and Pain Comorbidity
2003 Standout
Drug development for CNS disorders: strategies for balancing risk and reducing attrition
2007
Algorithms and Collaborative-care Systems for Depression: Are They Effective and Why?
2006
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
Augmentation strategies for treatment-resistant depression
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Drug-related hypertension and resistance to antihypertensive treatment
2011
The use of psychotropic drugs in irritable bowel syndrome
2013
Out-patient Compliance with Antidepressant Medication
1992
Clinical Use of Curcumin in Depression: A Meta-Analysis
2017
Treatment resistant depression: methodological overview and operational criteria
1999
Mining electronic health records: towards better research applications and clinical care
2012 Standout
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
1996
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Depression in Older Adults
2009 Standout
Irritable Bowel Syndrome
2015 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Dual–Dual Action? Combining Venlafaxine and Mirtazapine in the Treatment of Depression
2008
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Prevalence and management of treatment-resistant depression.
2007
Interventions for enhancing medication adherence
2008 Standout
Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study
2012
Depression and Coronary Heart Disease
2008 Standout
Beyond Tricyclics
2009
Interventions for enhancing medication adherence
2014 Standout
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Depression and coronary artery disease: the association, mechanisms, and therapeutic implications.
2009
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
“Cade's Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder
2002
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders
2007
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Works of Frederick Quitkin being referenced
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
A Typological Model for Estimation of Drug and Placebo Effects in Depression
2002
Efficacy and Safety of Fluoxetine in Treating Bipolar II Major Depressive Episode
1998
Treatment-Associated Suicidal Ideation and Adverse Effects in an Open, Multicenter Trial of Fluoxetine for Major Depressive Episodes
2006
Blood Pressure Changes During Short-Term Fluoxetine Treatment
1999
The Importance of Dosage in Prescribing Antidepressants
1985
Switching to Bupropion in Fluoxetine-Resistant Major Depressive Disorder
2003